Concepedia

Ruud Ruiter

RR

Statistics

Publications

7

Citations

411

H-Index

7

Active since

2019

Affiliations

Amsterdam University Medical Centers(Current)

Queen Mary University of London

Amsterdam UMC Location Vrije Universiteit Amsterdam

Sun Pharma Advanced Research (India)

Kuros Biosciences (Switzerland)

Ruud Ruiter is an author at Amsterdam University Medical Centers specializing in oncology, cancer immunotherapy, and multiple myeloma therapy.

ORCID

Publications per year

2019–2023

7

Publications

7

Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor–engineered T Cells

Esther Drent, Renée Poels, Ruud Ruiter et al. · Clinical Cancer Research · 2019 · 183 citations · Full text

, , +17

Combining a CAR and a chimeric costimulatory receptor enhances T cell sensitivity to low antigen density and promotes persistence

Afroditi Katsarou, Maria Sjöstrand, Jyoti Naik et al. · Science Translational Medicine · 2021 · 121 citations · Full text

, , +13

Liposomal dexamethasone inhibits tumor growth in an advanced human-mouse hybrid model of multiple myeloma

Anil K. Deshantri, Marcel H.A.M. Fens, Ruud Ruiter et al. · Journal of Controlled Release · 2019 · 37 citations · Full text

, , +10

CD38-specific Chimeric Antigen Receptor Expressing Natural Killer KHYG-1 Cells: A Proof of Concept for an “Off the Shelf” Therapy for Multiple Myeloma

Arwen Stikvoort, J. van der Schans, Subhashis Sarkar et al. · HemaSphere · 2021 · 23 citations · Full text

, , +17

Polymeric micelles loaded with carfilzomib increase tolerability in a humanized bone marrow-like scaffold mouse model

Aida Varela-Moreira, Demian van Straten, Heleen F. van Leur et al. · International Journal of Pharmaceutics X · 2020 · 20 citations · Full text

, , +17

1–5 of 7